Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 27, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons in the company's Ordinary Shares, specifically relating to the GlaxoSmithKline Employee Trust ("GSK Trust").
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on share transaction details rather than financial performance metrics.
Material Changes and Transactions
The filing details specific transactions executed by Abacus (GSK) Trustees Limited on behalf of the GSK Trust between January 24 and January 25, 2006:
- January 24, 2006: Sold 784 Ordinary Shares at GBP 14.34401 per share for the SmithKline Beecham Mid-Term Incentive Plan.
- January 24, 2006: Transferred 1,128 Ordinary Shares to participants in the SmithKline Beecham Mid-Term Incentive Plan.
- January 25, 2006: Sold 1,568 Ordinary Shares at GBP 14.3728 per share for the SmithKline Beecham Mid-Term Incentive Plan.
- January 25, 2006: Transferred 2,256 Ordinary Shares to participants in the SmithKline Beecham Mid-Term Incentive Plan.
- January 25, 2006: Transferred 4,670 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991.
Three directors (Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop) are noted as having an interest in the shares held in the GSK Trust in the same capacity as other employees.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is a regulatory notification of share movements and does not contain forward-looking statements or risk assessments.
Key Facts for Investor Verification
- Verify the total number of shares sold versus transferred to understand the net impact on the trust's holdings.
- Confirm the specific share prices (GBP 14.34401 and GBP 14.3728) against market data for January 24-25, 2006.
- Note that the transactions relate to legacy incentive plans (SmithKline Beecham Mid-Term Incentive Plan and Employee Share Option Plan 1991).
- Recognize that this filing does not contain financial performance data for the period.